Thomas Stranzl
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 8
- Cancer-related Molecular Pathways 2
-
- Metabolomics and Mass Spectrometry Studies 2
- Co-authors
- Mette Voldby Larsen (2 shared papers)Morten Nielsen (2 shared papers)Claus Lundegaard (2 shared papers)Karl Mechtler (4 shared papers)Martin Filipits (14 shared papers)Robert Pirker (13 shared papers)Gudrun Pohl (13 shared papers)Peter Pichler (2 shared papers)
- Journals
- Advances in experimental medicine and biology (2 papers)Blood (2 papers)Journal of Proteome Research (2 papers)Leukemia (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- AustriaDenmarkUnited States
In The Last Decade
Thomas Stranzl
26 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 98
- Hematology 226
- Oncology 405
- Genetics 143
- Spectroscopy 231
- Molecular Biology 863
Countries citing papers authored by Thomas Stranzl
This map shows the geographic impact of Thomas Stranzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Stranzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Stranzl more than expected).
Fields of papers citing papers by Thomas Stranzl
This network shows the impact of papers produced by Thomas Stranzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Stranzl. The network helps show where Thomas Stranzl may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Stranzl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 340 | |
| 2 | 2010 | 303 | |
| 3 | 2008 | 232 | |
| 4 | 1998 | 92 | |
| 5 | Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. | 2002 | 77 |
| 6 | 2003 | 71 | |
| 7 | 2019 | 62 | |
| 8 | 2018 | 51 | |
| 9 | 2000 | 50 | |
| 10 | 2003 | 48 | |
| 11 | Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma. | 1999 | 39 |
| 12 | 2013 | 35 | |
| 13 | 2015 | 33 | |
| 14 | 1999 | 27 | |
| 15 | Expression of the multidrug resistance protein (MRP1) in breast cancer. | 2000 | 27 |
| 16 | Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma. | 2003 | 26 |
| 17 | Expression of the lung resistance protein (LRP) in primary breast cancer. | 2000 | 20 |
| 18 | Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis. | 2003 | 19 |
| 19 | 2016 | 17 | |
| 20 | 1999 | 14 |
About Thomas Stranzl
Thomas Stranzl is a scholar working on Oncology, Molecular Biology, Genetics, Hematology and Immunology and Allergy, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Allergic Rhinitis and Sensitization (5 papers), Mass Spectrometry Techniques and Applications (4 papers), Acute Myeloid Leukemia Research (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Cancer-related Molecular Pathways (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Hematology (226 citations), Oncology (405 citations), Genetics (143 citations), Spectroscopy (231 citations) and Molecular Biology (863 citations). Thomas Stranzl has collaborated with scholars based in Austria, Denmark and United States. Frequent co-authors include Mette Voldby Larsen, Morten Nielsen, Claus Lundegaard, Karl Mechtler, Martin Filipits, Robert Pirker, Gudrun Pohl, Peter Pichler, Johannes Stadlmann and Thomas Taus. Their work appears in journals such as Advances in experimental medicine and biology, Blood, Journal of Proteome Research, Leukemia and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.